Mirae Asset Global Investments Co., Ltd.
Position in DNLI — Denali Therapeutics Inc.
CIK 1569395
SEOUL, M5
Position in DNLI
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$182,560
+$23,738 QoQ
Shares Held
7,098
-14.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#199
of 290 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. DNLI ranks #56 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,209 | $104,417,115 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
93,632 | $58,383,296 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,531 | $18,522,675 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,420 | $17,944,868 | |
| 5 | ARGX |
Argenx SE
|
11,164 | $10,357,623 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
33,808 | $9,634,265 | |
| 7 | RPRX |
Royalty Pharma plc
|
150,556 | $8,441,674 | |
| 8 | INCY |
Incyte Corp
|
63,812 | $7,233,728 |
All Filings in DNLI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $182,560 | 7,098 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $158,822 | 8,272 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $117,666 | 7,127 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $82,081 | 5,653 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $78,511 | 5,612 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $66,058 | 4,859 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $97,742 | 4,796 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $150,835 | 5,178 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $98,870 | 4,258 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,459,832 | 71,142 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,579,133 | 73,585 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,437,373 | 69,674 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $2,056,196 | 69,678 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,543,171 | 66,978 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $1,518,619 | 54,607 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,500,678 | 48,898 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,036,936 | 35,234 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $354,006 | 7,017 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $459,343 | 5,856 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||